Maze Therapeutics
A Senior Director of Pharmaceutical Development leads small molecule drug product activities and serves as a technical expert overseeing processes at CDMOs. They guide formulation and process development, manage scaleups, and identify risks, gaps, and solutions across CMC.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2018
Maze Therapeutics (branded "Genetic Navigators") is a biotechnology company that translates human genetic data into validated drug targets. They combine large-scale human genetics, computational analysis, and functional genomics to prioritize targets with strong causal evidence. Their platform is designed to accelerate and de-risk drug discovery, supporting internal development programs and collaborations with partners to advance new therapies.
Foresite Capital Management IV LLC Sells 1,589,262 Shares of Maze Therapeutics, Inc. $MAZE
11 hours ago
Foresite Capital Management V LLC Sells 258,900 Shares of Maze Therapeutics, Inc. $MAZE
11 hours ago
Maze Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference
3 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Maze Therapeutics.
108% above the average for this role
Maze Therapeutics Executive Sells All Common Stock Holdings
4 days ago
Associate Director, CMC Product Development – Small Molecule
Beeline Medicines
Director, CMC Product Development – Small Molecule
Beeline Medicines
Executive Director, Pharmaceutical Development (Solid Orals)
lifelancer
Director, Pharmaceutics
ardelyx
Director, Pharmaceutical Development
Nurix
Associate Director, CMC Drug Product
Eikon Therapeutics